Press Releases
December 12, 2019
VIVO Announces Stock Option Grants
VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that it has granted, effective today, an aggregate of 3,364,500 stock options (each, an “Option”) to…
Read MoreNovember 14, 2019
VIVO Cannabis™ Reports Third Quarter 2019 Results
Net revenue was $6.3 million in the quarter, a 19% increase, quarter-over-quarter, and 175% increase over Q3 2018, and $16.6 million year-to-date, a 328% increase over the same period last year….
Read MoreNovember 12, 2019
VIVO Cannabis Receives Conditional Approval to Graduate to the Toronto Stock Exchange
VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to graduate…
Read MoreNovember 1, 2019
VIVO Cannabis to Host Third Quarter 2019 Financial Results Conference Call
VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that senior management will host a conference call to discuss the Company’s third quarter 2019 results. The…
Read MoreOctober 29, 2019
VIVO and CB2 Insights Enter Technology and Research Partnership
Partnership to focus on implementing a medical product development strategy for VIVO’s global medical cannabis offering, utilizing CB2 Insights’ leading technology platform Sail and research…
Read MoreOctober 3, 2019
VIVO Cannabis™ Reaffirms Timing of First Harvest at Kimmetts and Additional 2020 Cultivation Plans
Announcements made during VIVO’s Analyst and Investor Day Held at Napanee Operations NAPANEE, ON, Oct. 3, 2019 /CNW/ – VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”)…
Read MoreSeptember 17, 2019
VIVO Cannabis™ Partners with Linneo Health to Supply Medical Cannabis in Europe
VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced it has partnered with Linneo Health S.L. (“Linneo Health”), a subsidiary of Alcaliber S.A., to be its…
Read MoreAugust 28, 2019
VIVO Cannabis™ Reports Q2 2019 Financial and Operating Results
Net revenue was $5.3 million in the quarter, a five-fold increase over the same quarter last year. Cultivation license was granted in the third quarter of 2019 for four new seasonal greenhouses in…
Read MoreAugust 15, 2019
VIVO Cannabis to Host Second Quarter 2019 Financial Results Conference Call
VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that senior management will host a conference call to discuss the Company’s second quarter 2019 results….
Read MoreAugust 6, 2019
VIVO Announces 50% Increase in Licensed Capacity and Third Licensed Site with New Innovative Seasonal Greenhouses
VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) today announced that the Company’s wholly-owned subsidiary, ABcann Medicinals Inc., has been granted a Standard Cultivation…
Read More
